Per ulteriori informazioni selezionare i riferimenti di interesse.
Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial
BLOOD
Mobilization of hematopoietic stem cells
BLOOD REVIEWS
A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients
BONE MARROW TRANSPLANTATION
Dermatologic changes associated with roquinimex immunotherapy after autologous bone marrow transplant
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Effect of nitric oxide production and oxygen tension on progenitor preservation in ex vivo culture
EXPERIMENTAL HEMATOLOGY
ERYTHROPOIETIN-RECEPTOR EXPRESSION AND FUNCTION DURING THE INITIATIONOF MURINE YOLK-SAC ERYTHROPOIESIS
Experimental hematology
HETEROGENEITY OF CLINICAL-RESPONSES TO ROQUINIMEX IMMUNOTHERAPY IN THE SETTING OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Journal of investigative dermatology
PRIMITIVE ERYTHROPOIESIS IN YOLK-SAC EXPLANTS IS INHIBITED BY ANTISENSE ERYTHROPOIETIN-RECEPTOR, C-RAF, AND JAK2 OLIGODEOXYNUCLEOTIDES (ODN)
Pediatric research
ERYTHROPOIETIN-RECEPTOR (EPO-R) SIGNALING IN MURINE YOLK-SAC EXPLANTS
Blood
AUTOTRANSPLANTATION FOR RELAPSED REFRACTORY NHL - COMPARABLE OUTCOMESFOR LOW-GRADE AND INTERMEDIATE/HIGH-GRADE HISTOLOGIES/
Blood
AUTOGRAFTING IN CHRONIC MYELOGENOUS LEUKEMIA FOLLOWED BY IMMUNOTHERAPY
Stem cells